- Home
- VANI vs MFC Comparison
VANI vs MFC Comparison
Compare VANI & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- MFC
- Stock Information
- Founded
- VANI 1998
- MFC 1887
- Country
- VANI United States
- MFC Canada
- Employees
- VANI N/A
- MFC N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MFC Life Insurance
- Sector
- VANI Health Care
- MFC Finance
- Exchange
- VANI Nasdaq
- MFC Nasdaq
- Market Cap
- VANI 75.8M
- MFC 51.7B
- IPO Year
- VANI 2014
- MFC 1999
- Fundamental
- Price
- VANI $1.27
- MFC $32.35
- Analyst Decision
- VANI Strong Buy
- MFC Buy
- Analyst Count
- VANI 1
- MFC 1
- Target Price
- VANI $4.00
- MFC $49.00
- AVG Volume (30 Days)
- VANI 52.2K
- MFC 2.1M
- Earning Date
- VANI 11-12-2025
- MFC 11-05-2025
- Dividend Yield
- VANI N/A
- MFC 3.79%
- EPS Growth
- VANI N/A
- MFC 33.03
- EPS
- VANI N/A
- MFC 2.29
- Revenue
- VANI N/A
- MFC $22,915,108,577.00
- Revenue This Year
- VANI N/A
- MFC $34.27
- Revenue Next Year
- VANI N/A
- MFC $8.25
- P/E Ratio
- VANI N/A
- MFC $14.10
- Revenue Growth
- VANI N/A
- MFC 9.72
- 52 Week Low
- VANI $0.91
- MFC $25.92
- 52 Week High
- VANI $1.80
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- VANI 50.75
- MFC 69.30
- Support Level
- VANI $1.19
- MFC $30.49
- Resistance Level
- VANI $1.40
- MFC $31.04
- Average True Range (ATR)
- VANI 0.07
- MFC 0.44
- MACD
- VANI 0.01
- MFC 0.21
- Stochastic Oscillator
- VANI 50.00
- MFC 100.00
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About MFC Manulife Financial Corporation
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings and is one of the top 20 life insurers in the US. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.